One-year incidence of psychosocial therapy initiation was 12.6 percent, while incidence of medication initiation was 2.8 percent
Age-dependent U-shaped trajectories seen for depression and anxiety; symptom levels were significantly higher for survivors
REM inhibition via receipt of antidepressant medications associated with trend toward survival benefit
Maximal survival benefit seen for smoking cessation treatment within six months of diagnosis
Caregiver anxiety and neighborhood factors associated with greater symptom burden
Alprazolam reduced IL-6 in human pancreatic cancer-associated fibroblasts and was associated with improved progression-free survival
Threshold effect seen with meaningful benefit for participating in social activity almost every day
Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years
Life challenges more negatively impacted in younger, female, relapsed patients; socializing more positively impacted in older patients
Authors say these estimates are similar to estimates in hospitalized patients